358 related articles for article (PubMed ID: 19479486)
1. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
Tang SC
Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
[TBL] [Abstract][Full Text] [Related]
2. Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
Tang SC
Cancer Invest; 2009 Feb; 27(2):206-14. PubMed ID: 19235594
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
[TBL] [Abstract][Full Text] [Related]
4. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
5. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
[TBL] [Abstract][Full Text] [Related]
6. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
[TBL] [Abstract][Full Text] [Related]
7. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
8. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
Rivera E
Am J Clin Oncol; 2010 Apr; 33(2):176-85. PubMed ID: 19675449
[TBL] [Abstract][Full Text] [Related]
9. Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer.
Pal SK; Childs BH; Pegram M
Breast Cancer Res Treat; 2010 Jan; 119(1):25-32. PubMed ID: 19795206
[TBL] [Abstract][Full Text] [Related]
10. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
11. Combined anthracycline-taxane regimens in the adjuvant setting.
Mamounas EP; Sledge GW
Semin Oncol; 2001 Aug; 28(4 Suppl 12):24-31. PubMed ID: 11552227
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant taxanes: more to the story.
Gajria D; Seidman A; Dang C
Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
[TBL] [Abstract][Full Text] [Related]
13. Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.
Martin M; Mackey J; Vogel C
Breast; 2007 Dec; 16 Suppl 2():S127-31. PubMed ID: 17923408
[TBL] [Abstract][Full Text] [Related]
14. Advances in adjuvant chemotherapy for breast cancer: the role of taxanes.
Kaklamani VG; Gradishar WJ
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S107-18. PubMed ID: 19795584
[TBL] [Abstract][Full Text] [Related]
15. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma.
Bria E; Giannarelli D; Felici A; Peters WP; Nisticò C; Vanni B; Cuppone F; Cognetti F; Terzoli E
Cancer; 2005 Feb; 103(4):672-9. PubMed ID: 15637696
[TBL] [Abstract][Full Text] [Related]
16. Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials.
Shao N; Wang S; Yao C; Xu X; Zhang Y; Zhang Y; Lin Y
Breast; 2012 Jun; 21(3):389-93. PubMed ID: 22542064
[TBL] [Abstract][Full Text] [Related]
17. Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes.
Murphy CG; Seidman AD
Clin Breast Cancer; 2009 Jun; 9 Suppl 2():S58-65. PubMed ID: 19596644
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?
Oakman C; Pestrin M; Cantisani E; Licitra S; DeStefanis M; Biganzoli L; Di Leo A
Breast; 2009 Oct; 18 Suppl 3():S18-24. PubMed ID: 19914536
[TBL] [Abstract][Full Text] [Related]
19. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
20. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
